Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celldex Therapeutics (CLDX) Amortization of Goodwill (2018)

Celldex Therapeutics has reported Amortization of Goodwill over the past 1 years, most recently at -$24000.0 for Q2 2018.

  • Quarterly results put Amortization of Goodwill at -$24000.0 for Q2 2018, changed N/A from a year ago — trailing twelve months through Dec 2018 was $91.0 million (changed N/A YoY), and the annual figure for FY2018 was $91.0 million, changed.
  • Amortization of Goodwill for Q2 2018 was -$24000.0 at Celldex Therapeutics, down from $91.0 million in the prior quarter.
  • Over the last five years, Amortization of Goodwill for CLDX hit a ceiling of $91.0 million in Q1 2018 and a floor of -$24000.0 in Q2 2018.